Moderna, Inc.
MRNA
$26.26
-$0.46-1.72%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.03B | 3.11B | 4.96B | 4.90B | 5.01B |
| Total Other Revenue | 149.00M | 127.00M | 117.00M | 149.00M | 143.00M |
| Total Revenue | 3.18B | 3.24B | 5.08B | 5.05B | 5.15B |
| Cost of Revenue | 5.79B | 6.01B | 6.48B | 8.23B | 8.77B |
| Gross Profit | -2.62B | -2.77B | -1.40B | -3.18B | -3.62B |
| SG&A Expenses | 1.11B | 1.17B | 1.29B | 1.45B | 1.52B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.91B | 7.18B | 7.77B | 9.69B | 10.29B |
| Operating Income | -3.73B | -3.95B | -2.69B | -4.64B | -5.14B |
| Income Before Tax | -3.41B | -3.61B | -2.35B | -4.33B | -4.80B |
| Income Tax Expenses | -49.00M | -46.00M | -129.00M | 1.54B | 1.17B |
| Earnings from Continuing Operations | -3.36K | -3.56K | -2.22K | -5.87K | -5.97K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.36B | -3.56B | -2.22B | -5.87B | -5.97B |
| EBIT | -3.73B | -3.95B | -2.69B | -4.64B | -5.14B |
| EBITDA | -3.54B | -3.76B | -2.36B | -4.11B | -4.56B |
| EPS Basic | -8.72 | -9.28 | -5.80 | -15.36 | -15.66 |
| Normalized Basic EPS | -5.45 | -5.78 | -3.73 | -6.93 | -7.79 |
| EPS Diluted | -8.74 | -9.30 | -5.84 | -15.40 | -15.69 |
| Normalized Diluted EPS | -5.45 | -5.79 | -3.73 | -6.93 | -7.79 |
| Average Basic Shares Outstanding | 1.54B | 1.54B | 1.53B | 1.53B | 1.53B |
| Average Diluted Shares Outstanding | 1.55B | 1.55B | 1.56B | 1.54B | 1.54B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |